perhaps the value lies in the fact that the can safely inject R327 into a patient but they can't inject bleach, to kill these bacteria. As for their inablity to recruit patients... That seems worth noting. Was there any explanation as to why they weren't able to recruit more patients?
Correct me if I'm wrong but I seem to recall seeing a number of photos of healed diabetic ulcers which had not responded to the conventional protocols....was this unrelated or irrelevant? Serious question... always appreciate being better informed.
Ann: R327 Efficacy against WHO Priority Pathogen Acinetobacter B, page-6
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
49.5¢ |
Change
0.010(2.06%) |
Mkt cap ! $114.6M | |||
| Open | High | Low | Value | Volume |
| 48.5¢ | 51.0¢ | 48.5¢ | $1.909K | 3.908K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 15775 | 48.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 49.5¢ | 66869 | 2 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| RCE (ASX) Chart |